This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2020-2025.
Location History:
- Welwyn Garden, GB (2020)
- Welwyn Garden City, GB (2023)
Company Filing History:
3 out of 3,292 
3 out of 5,016 
Years Active: 2020-2025
Title: The Innovative Contributions of Sarah Heeson
Introduction
Sarah Heeson is a prominent inventor based in Welwyn Garden, GB. She has made significant contributions to the field of cancer treatment through her innovative patents. With a total of 3 patents, her work focuses on improving the efficacy and safety of HER2 antibody formulations.
Latest Patents
One of her latest patents is the "Pertuzumab plus trastuzumab fixed dose combination." This invention concerns a fixed dose combination (FDC) of pertuzumab, trastuzumab, and, optionally, recombinant human hyaluronidase (rHuPH20), which is administered subcutaneously to patients. The patent discloses the final efficacy and safety data for the FeDeriCa clinical trial, along with the United States Prescribing Information (USPI) and primary analysis of the PHranceSCa clinical trial. Another significant patent is for "Subcutaneous HER2 antibody formulations." This patent provides fixed dose HER2 antibody formulations for subcutaneous administration, including fixed dose subcutaneous formulations of pertuzumab and co-formulations of pertuzumab and trastuzumab, aimed at treating cancer.
Career Highlights
Throughout her career, Sarah has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. Her expertise in developing innovative cancer treatments has positioned her as a key figure in her field.
Collaborations
Sarah has collaborated with notable coworkers such as Whitney Kirschbrown and Tanja Badovinac-Crnjevic. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Sarah Heeson's contributions to cancer treatment through her innovative patents highlight her dedication to improving patient outcomes. Her work continues to influence the field and inspire future innovations.